Acetylon Pharmaceuticals, Inc. — Form D
Acetylon Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-02-22. The offering totals $30.0M, of which $12.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-02-22
- Form: D
- Accession: 0001469566-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $30.0M
- Amount sold: $12.4M
- Remaining: $17.6M
- Investors: 23
- Date of first sale: 2011-02-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-155652
Issuer
- Name: Acetylon Pharmaceuticals, Inc.
- CIK: 0001469566
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: Seaport Center, BOSTON, MA, 02210
- Phone: 617-245-1300
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Kenneth Anderson | Director | Wellesley, MA |
| Elena A Prokupets | Director | Cambridge, MA |
| Marc A Cohen | Director | Cambridge, MA |
| Marc A Cohen | Executive Officer | Cambridge, MA |
| Kenneth A Anderson | Director | Cambridge, MA |
| Walter A Ogier | Director | Irvine, CA |
| Walter A Ogier | Executive Officer | Irvine, CA |
| Bruce L Downey | Director | Radnor, PA |
| WALTER C OGIER | Director | CAMBRIDGE, MA |
| WALTER C OGIER | Executive Officer | CAMBRIDGE, MA |
| Elena Prokupets | Director | North Andover, MA |
| Bruce A Downey | Director | Boston, MA |
| James A Bradner | Director | Boston, MA |
| James Bradner | Director | Boston, MA |
Other filings by this issuer (2)
More